Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Guardant Health Inc (NASDAQ: GH) closed at $43.85 in the last session, up 2.21% from day before closing price of $42.90. In other words, the price has increased by $2.21 from its previous closing price. On the day, 1.5 million shares were traded. GH stock price reached its highest trading level at $44.03 during the session, while it also had its lowest trading level at $40.88.
Ratios:
We take a closer look at GH’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.36 and its Current Ratio is at 4.68.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Barclays on January 23, 2025, initiated with a Overweight rating and assigned the stock a target price of $60.
On June 28, 2024, Guggenheim Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $36.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 17 ’25 when Kalia Kumud sold 3,500 shares for $43.16 per share. The transaction valued at 151,060 led to the insider holds 19,720 shares of the business.
Kalia Kumud bought 3,500 shares of GH for $151,060 on Mar 17 ’25. On Mar 03 ’25, another insider, Joyce Meghan V., who serves as the Director of the company, sold 100 shares for $42.71 each. As a result, the insider received 4,271 and left with 7,647 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GH now has a Market Capitalization of 5412010496 and an Enterprise Value of 5908104192. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.32. Its current Enterprise Value per Revenue stands at 7.995 whereas that against EBITDA is -14.726.
Stock Price History:
The Beta on a monthly basis for GH is 1.46, which has changed by 1.445622 over the last 52 weeks, in comparison to a change of 0.07465422 over the same period for the S&P500. Over the past 52 weeks, GH has reached a high of $50.89, while it has fallen to a 52-week low of $15.81. The 50-Day Moving Average of the stock is 1.98%, while the 200-Day Moving Average is calculated to be 36.78%.
Shares Statistics:
According to the various share statistics, GH traded on average about 2.37M shares per day over the past 3-months and 2444040 shares per day over the past 10 days. A total of 123.99M shares are outstanding, with a floating share count of 118.00M. Insiders hold about 4.39% of the company’s shares, while institutions hold 96.28% stake in the company. Shares short for GH as of 1740700800 were 7897769 with a Short Ratio of 3.33, compared to 1738281600 on 5771757. Therefore, it implies a Short% of Shares Outstanding of 7897769 and a Short% of Float of 6.670000399999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
